WoolAid Forced Offshore as NZ Wool Processing Hollows Out

WoolAid Forced Offshore as NZ Wool Processing Hollows Out

Summary

The supply chain of WoolAid, a New Zealand merino wool medical bandage company, illustrates how the hollowing out of the country's wool processing industry has made 'local value-add' difficult to achieve. Founder Lucas Smith established the company in 2019, sourcing ZQ-certified merino wool from Zentera farms in the Mackenzie Country, Central Otago and Marlborough. However, the wool is scoured, degreased, spun and woven in Italy, with the fabric then exported to Shanghai, where local factories process it into bandages meeting FDA Class I medical device standards before sale to markets from Shanghai.

Smith told RNZ this week that only a handful of factories worldwide have the processing capability, and none in New Zealand. RNZ reported the same arrangement as early as 2022, and four years later domestic options remain absent. The newly released Future of Fibre Aotearoa report identifies skills and manufacturing gaps in the fibre industry.

In June 2026 the industry warned that domestic wool scouring capacity was at critical risk, and in the same month Newsroom reported that 'Made in New Zealand' clothing was increasingly a global jigsaw puzzle. The article argues the issue is why private capital deems specialised processing uneconomic in New Zealand, involving factors such as energy prices, consent costs, scale and skilled labour, rather than a lack of marketing or promotion.

Commentary

The WoolAid case reveals a long-standing structural predicament in New Zealand's wool industry: despite possessing world-class merino wool raw material, the absence of local processing capacity forces companies to hand over high-value-added stages to Italy and China. This phenomenon is not isolated but a microcosm of the hollowing out of the entire fibre industry. The Future of Fibre Aotearoa report explicitly identifies skills and manufacturing gaps, while the June 2026 industry warning that domestic wool scouring capacity is at critical risk further confirms the urgency of the problem.

For New Zealand SME owners, this is not only a warning for the wool sector but also reflects broader manufacturing challenges—high energy costs, lengthy consent processes, shortages of skilled labour and diseconomies of scale—that deter private capital from local processing. From a commercial perspective, WoolAid's supply chain arrangement, though born of necessity, offers a survival model under global division of labour: leveraging Italy's textile expertise and China's manufacturing cost advantages to combine New Zealand's raw material brand with medical standards, ultimately achieving product exports. However, this model also means companies must bear risks such as exchange rate fluctuations, logistics delays and intellectual property spillovers, with most profits remaining overseas.

For farmers and brands relying on the local value-add narrative, this undoubtedly weakens the premium of 'Made in New Zealand'. It is worth noting that the government has invested considerably in wool promotion and research in recent years, but without physical processing capacity, these efforts are difficult to convert into local jobs and tax revenue. To turn the situation around, policymakers need to confront the core obstacles that deter private capital investment, rather than continuing to rely on marketing slogans.

For SMEs, a more pragmatic short-term strategy may be to actively embrace offshore processing while controlling key nodes of the value chain through patents, standards and brands, rather than insisting on local production.

Keywords: WoolAid, merino wool, wool processing, supply chain offshoring, wool scouring capacity, medical bandages, Lucas Smith, Future of Fibre Aotearoa, Made in New Zealand


Photo by MartinStr on Pixabay

Source: b2bnews.co.nz

Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.

Leave a Reply

Your email address will not be published. Required fields are marked *